Molecular Physiology & Biophysics Archives
Unleashing TIGER on small RNAs
Sep. 5, 2018—Vanderbilt investigators have developed a new analytical tool to identify, quantify and analyze small RNAs.
Gene mutation discovery may hold autism clues: study
Feb. 2, 2017—Researchers at Vanderbilt have identified what may be a genetic “smoking gun” for autism spectrum disorder (ASD) — a mutation in the gene for the critical neuronal protein CaMKII.
Protecting the blood-brain barrier
Dec. 9, 2016—Vanderbilt investigators have discovered how a promising cancer immunotherapy causes brain swelling, findings that could lead to ways to protect brain function while fighting cancers.
Making human beta cells reproduce
Dec. 8, 2016—A new method developed at Vanderbilt will speed the search for potential therapeutics for diabetes: compounds that stimulate the replication of insulin-producing beta cells.
Bioluminescent sensor causes brain cells to glow in the dark
Oct. 27, 2016—A team of Vanderbilt scientists have genetically modified luciferase, the enzyme that produces bioluminescence, so that it acts as an optical sensor that records activity in brain cells.
New center will examine addiction at molecular level, develop treatments
Aug. 17, 2016—Vanderbilt University researchers from diverse scientific disciplines are joining forces to help crack the stubborn mysteries of addiction through the new Vanderbilt Center for Addiction Research.
New culprit in nerve degeneration
Aug. 12, 2016—Vanderbilt researchers have discovered that regulation of cell volume plays a role in nerve degeneration and peripheral neuropathies.
Study reveals neurotransmitter glutamate’s molecular structure
Aug. 11, 2016—Terunaga Nakagawa, with colleagues from Japan and Oxford University in England, has discovered the bridgelike molecular structure of a mysterious glutamate receptor.
Award bolsters study of alcohol’s impact on the brain
Jul. 28, 2016—Vanderbilt University researcher Danny Winder, Ph.D., has received a MERIT Award from the National Institute of Alcohol Abuse and Addiction (NIAAA), part of the National Institutes of Health, for his contributions to understanding how alcohol affects the brain.
Diabetes drugs may ease addiction
Jul. 18, 2016—Drugs that are being used clinically to treat obesity and diabetes may also have a role in treating drug abuse.
Membrane fats impact drug transporter
Jul. 14, 2016—New studies of a membrane transporter could explain antibiotic resistance – and lead to novel ways to combat it.
Vanderbilt mourns loss of diabetes research icon ‘Rollo’ Park
May. 12, 2016—Charles Rawlinson “Rollo” Park, M.D., a pioneering diabetes researcher at Vanderbilt University Medical Center, died Saturday, May 7, at his home in Brentwood, just two months after celebrating his 100th birthday on March 2.